REFERENCES
1 Meier, R. K. Polycystic Ovary Syndrome. The Nursing clinics of
North America 53 , 407-420, doi:10.1016/j.cnur.2018.04.008
(2018).
2 Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan,
L. & Azziz, R. Criteria, prevalence, and phenotypes of polycystic ovary
syndrome. Fertility and Sterility 106 , 6-15,
doi:10.1016/j.fertnstert.2016.05.003 (2016).
3 ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Obstetrics and gynecology 131 , e157-e171,
doi:10.1097/aog.0000000000002656 (2018).
4 Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R.
S. et al. Polycystic ovary syndrome. Nat Rev Dis Primers2 , 16057, doi:10.1038/nrdp.2016.57 (2016).
5 Cela, V., Obino, M. E. R., Alberga, Y., Pinelli, S., Sergiampietri,
C., Casarosa, E. et al. Ovarian response to controlled ovarian
stimulation in women with different polycystic ovary syndrome
phenotypes. Gynecol Endocrinol 34 , 518-523,
doi:10.1080/09513590.2017.1412429 (2018).
6 Ramezanali, F., Ashrafi, M., Hemat, M., Arabipoor, A., Jalali, S. &
Moini, A. Assisted reproductive outcomes in women with different
polycystic ovary syndrome phenotypes: the predictive value of
anti-Mullerian hormone. Reprod Biomed Online 32 ,
503-512, doi:10.1016/j.rbmo.2016.01.010 (2016).
7 Tal, R., Seifer, D. B., Khanimov, M., Malter, H. E., Grazi, R. V. &
Leader, B. Characterization of women with elevated antimullerian hormone
levels (AMH): correlation of AMH with polycystic ovarian syndrome
phenotypes and assisted reproductive technology outcomes. Am J
Obstet Gynecol 211 , 59, e51-e58,
doi:10.1016/j.ajog.2014.02.026 (2014).
8 Mourad, S., Brown, J. & Farquhar, C. Interventions for the prevention
of OHSS in ART cycles: an overview of Cochrane reviews. The
Cochrane database of systematic reviews 1 , Cd012103,
doi:10.1002/14651858.CD012103.pub2 (2017).
9 Blumenfeld, Z. The Ovarian Hyperstimulation Syndrome. Vitam
Horm 107 , 423-451, doi:10.1016/bs.vh.2018.01.018 (2018).
10 Roque, M., Haahr, T., Geber, S., Esteves, S. C. & Humaidan, P. Fresh
versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic
review and meta-analysis of reproductive outcomes. Hum Reprod
Update 25 , 2-14, doi:10.1093/humupd/dmy033 (2019).
11 Chen, Z. J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y. et
al. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary
Syndrome. The New England journal of medicine 375 ,
523-533, doi:10.1056/NEJMoa1513873 (2016).
12 Singh, B., Reschke, L., Segars, J. & Baker, V. L. Frozen-thawed
embryo transfer: the potential importance of the corpus luteum in
preventing obstetrical complications. Fertil Steril 113 ,
252-257, doi:10.1016/j.fertnstert.2019.12.007 (2020).
13 Roos, N., Kieler, H., Sahlin, L., Ekman-Ordeberg, G., Falconer, H. &
Stephansson, O. Risk of adverse pregnancy outcomes in women with
polycystic ovary syndrome: population based cohort study. Bmj343 , d6309, doi:10.1136/bmj.d6309 (2011).
14 Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P., La Sala, G.
B. & Fauser, B. C. Pregnancy complications in women with polycystic
ovary syndrome. Hum Reprod Update 21 , 575-592,
doi:10.1093/humupd/dmv029 (2015).
15 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised
2003 consensus on diagnostic criteria and long-term health risks related
to polycystic ovary syndrome. Fertility and Sterility81 , 19-25, doi:10.1016/j.fertnstert.2003.10.004 (2004).
16 Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic
ovary syndrome. The Lancet 370 , 685-697,
doi:10.1016/s0140-6736(07)61345-2 (2007).
17 Qiu, M., Tao, Y., Kuang, Y. & Wang, Y. Effect of body mass index on
pregnancy outcomes with the freeze-all strategy in women with polycystic
ovarian syndrome. Fertil Steril 112 , 1172-1179,
doi:10.1016/j.fertnstert.2019.08.009 (2019).
18 Sun, Y. F., Zhang, J., Xu, Y. M., Cao, Z. Y., Wang, Y. Z., Hao, G. M.et al. High BMI and Insulin Resistance Are Risk Factors for
Spontaneous Abortion in Patients With Polycystic Ovary Syndrome
Undergoing Assisted Reproductive Treatment: A Systematic Review and
Meta-Analysis. Frontiers in endocrinology 11 , 592495,
doi:10.3389/fendo.2020.592495 (2020).
19 Zhang, Y., Zhao, W., Xu, H., Hu, M., Guo, X., Jia, W. et al.Hyperandrogenism and insulin resistance-induced fetal loss: evidence for
placental mitochondrial abnormalities and elevated reactive oxygen
species production in pregnant rats that mimic the clinical features of
polycystic ovary syndrome. The Journal of physiology597 , 3927-3950, doi:10.1113/jp277879 (2019).
20 Song, J., Wang, X., Guo, Y., Yang, Y., Xu, K., Wang, T. et al.Novel high-coverage targeted metabolomics method (SWATHtoMRM) for
exploring follicular fluid metabolome alterations in women with
recurrent spontaneous abortion undergoing in vitro fertilization.Scientific reports 9 , 10873,
doi:10.1038/s41598-019-47370-7 (2019).
21 Legro, R. S. Pregnancy considerations in women with polycystic ovary
syndrome. Clin Obstet Gynecol 50 , 295-304,
doi:10.1097/GRF.0b013e31803057ed (2007).
22 van der Spuy, Z. M. & Dyer, S. J. The pathogenesis of infertility
and early pregnancy loss in polycystic ovary syndrome. Best Pract
Res Clin Obstet Gynaecol 18 , 755-771,
doi:10.1016/j.bpobgyn.2004.06.001 (2004).
23 Yu, H. F., Chen, H. S., Rao, D. P. & Gong, J. Association between
polycystic ovary syndrome and the risk of pregnancy complications: A
PRISMA-compliant systematic review and meta-analysis. Medicine95 , e4863, doi:10.1097/md.0000000000004863 (2016).
24 Zehravi, M., Maqbool, M. & Ara, I. Polycystic ovary syndrome and
reproductive health of women: a curious association. International
journal of adolescent medicine and health , doi:10.1515/ijamh-2021-0031
(2021).
25 Wang, J. X., Norman, R. J. & Wilcox, A. J. Incidence of spontaneous
abortion among pregnancies produced by assisted reproductive technology.Hum Reprod 19 , 272-277, doi:10.1093/humrep/deh078
(2004).
26 Barnes, F. L., Kausche, A., Tiglias, J., Wood, C., Wilton, L. &
Trounson, A. Production of embryos from in vitro-matured primary human
oocytes. Fertil Steril 65 , 1151-1156,
doi:10.1016/s0015-0282(16)58330-7 (1996).
27 Santos, J. E., Bisinotto, R. S. & Ribeiro, E. S. Mechanisms
underlying reduced fertility in anovular dairy cows.Theriogenology 86 , 254-262,
doi:10.1016/j.theriogenology.2016.04.038 (2016).
28 Jia, L., Li, J., He, B., Jia, Y., Niu, Y., Wang, C. et al.Abnormally activated one-carbon metabolic pathway is associated with
mtDNA hypermethylation and mitochondrial malfunction in the oocytes of
polycystic gilt ovaries. Scientific reports 6 , 19436,
doi:10.1038/srep19436 (2016).
29 Aslih, N., Dorzia, D., Atzmon, Y., Estrada, D., Ellenbogen, A.,
Bilgory, A. et al. Ovulatory-Based FET Cycles May Achieve Higher
Pregnancy Rates in the General Population and among Anovulatory Women.Journal of clinical medicine 10 , doi:10.3390/jcm10040703
(2021).
30 Xu, H., Qiu, S., Chen, X., Zhu, S., Sun, Y. & Zheng, B. D6
blastocyst transfer on day 6 in frozen-thawed cycles should be avoided:
a retrospective cohort study. BMC Pregnancy Childbirth20 , 519, doi:10.1186/s12884-020-03224-z (2020).
31 Cerrillo, M., Herrero, L., Guillén, A., Mayoral, M. &
García-Velasco, J. A. Impact of Endometrial Preparation Protocols for
Frozen Embryo Transfer on Live Birth Rates. Rambam Maimonides
medical journal 8 , doi:10.5041/rmmj.10297 (2017).
32 Liu, X., Shi, W. & Shi, J. Natural cycle frozen-thawed embryo
transfer in young women with regular menstrual cycles increases the
live-birth rates compared with hormone replacement treatment: a
retrospective cohort study. Fertil Steril 113 , 811-817,
doi:10.1016/j.fertnstert.2019.11.023 (2020).
33 Patel, S., Kilburn, B., Imudia, A., Armant, D. R. & Skafar, D. F.
Estradiol Elicits Proapoptotic and Antiproliferative Effects in Human
Trophoblast Cells. Biol Reprod 93 , 74,
doi:10.1095/biolreprod.115.129114 (2015).
34 Hancke, K., More, S., Kreienberg, R. & Weiss, J. M. Patients
undergoing frozen-thawed embryo transfer have similar live birth rates
in spontaneous and artificial cycles. J Assist Reprod Genet29 , 403-407, doi:10.1007/s10815-012-9724-z (2012).
35 Talmor, A. & Dunphy, B. Female obesity and infertility. Best
Pract Res Clin Obstet Gynaecol 29 , 498-506,
doi:10.1016/j.bpobgyn.2014.10.014 (2015).
36 Metwally, M., Ong, K. J., Ledger, W. L. & Li, T. C. Does high body
mass index increase the risk of miscarriage after spontaneous and
assisted conception? A meta-analysis of the evidence. Fertil
Steril 90 , 714-726, doi:10.1016/j.fertnstert.2007.07.1290
(2008).
37 Bellver, J., Rossal, L. P., Bosch, E., Zúñiga, A., Corona, J. T.,
Meléndez, F. et al. Obesity and the risk of spontaneous abortion
after oocyte donation. Fertil Steril 79 , 1136-1140,
doi:10.1016/s0015-0282(03)00176-6 (2003).
38 Zhou, H., Zhang, D., Luo, Z., Yang, A., Cui, N., Hao, G. et
al. Association between Body Mass Index and Reproductive Outcome in
Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET. BioMed
research international 2020 , 6434080, doi:10.1155/2020/6434080
(2020).
39 Metwally, M., Cutting, R., Tipton, A., Skull, J., Ledger, W. L. &
Li, T. C. Effect of increased body mass index on oocyte and embryo
quality in IVF patients. Reprod Biomed Online 15 ,
532-538, doi:10.1016/s1472-6483(10)60385-9 (2007).
40 Li, X., Ding, W., Liu, J. Y., Mao, Y. D., Huang, J., Wang, W.et al. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome
in patients with polycystic ovary syndrome]. Zhonghua Fu Chan Ke
Za Zhi 53 , 402-408,
doi:10.3760/cma.j.issn.0529-567x.2018.06.008 (2018).
41 Lee, Y. S., Biddle, S., Chan, M. F., Cheng, A., Cheong, M., Chong, Y.
S. et al. Health Promotion Board-Ministry of Health Clinical
Practice Guidelines: Obesity. Singapore medical journal57 , 472, doi:10.11622/smedj.2016141 (2016).
42 Magnus, M. C., Wilcox, A. J., Morken, N. H., Weinberg, C. R. &
Håberg, S. E. Role of maternal age and pregnancy history in risk of
miscarriage: prospective register based study. Bmj 364 ,
l869, doi:10.1136/bmj.l869 (2019).
43 du Fossé, N. A., van der Hoorn, M. P., van Lith, J. M. M., le Cessie,
S. & Lashley, E. Advanced paternal age is associated with an increased
risk of spontaneous miscarriage: a systematic review and meta-analysis.Hum Reprod Update 26 , 650-669,
doi:10.1093/humupd/dmaa010 (2020).
44 Li, J., Liu, X., Hu, L., Zhang, F., Wang, F., Kong, H. et al.A Slower Age-Related Decline in Treatment Outcomes After the First
Ovarian Stimulation for in vitro Fertilization in Women With Polycystic
Ovary Syndrome. Frontiers in endocrinology 10 , 834,
doi:10.3389/fendo.2019.00834 (2019).
45 Weghofer, A., Munne, S., Chen, S., Barad, D. & Gleicher, N. Lack of
association between polycystic ovary syndrome and embryonic aneuploidy.Fertil Steril 88 , 900-905,
doi:10.1016/j.fertnstert.2006.12.018 (2007).
46 Yang, W., Yang, R., Yang, S., Li, J., Tu, B., Gao, C. et al.Infertile polycystic ovary syndrome patients undergoing in vitro
fertilization with the gonadotropin-releasing hormone-antagonist
protocol: role of hyperandrogenism. Gynecol Endocrinol34 , 715-718, doi:10.1080/09513590.2018.1431773 (2018).
Table 1. Baseline characteristics and ovarian responses
of
four PCOS phenotype and control groups